Universal Pain Management Medical Corporation
Universal Pain Management Medical Corporation was paid $6.84M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 49% of everything it billed.
33Billing provider infoUNIVERSAL PAIN MANAGEMENT MEDICAL CORPORATION
PALMDALE, CA 93551
PALMDALE, CA 93551
33aNPI1427046655assigned 10/11/2005
33bProvider typeSpecialist
28Total paid$6.84M
24GClaims104,121
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#32 of 1,230
Median peer was paid$51K
This provider vs. median133×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,579 | $266K | |
| 2019 | 13,496 | $623K | |
| 2020 | 16,153 | $915K | |
| 2021 | 14,614 | $1.17M | |
| 2022 | 16,403 | $1.26M | |
| 2023 | 18,337 | $1.37M | |
| 2024incomplete | 14,539 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 49% | 36,260 | 34,675 | $3.36M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 48,695 | 46,383 | $2.86M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.8% | 5,285 | 5,223 | $258K |
| 99443 | 1.1% | 2,241 | 2,183 | $75K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.0% | 732 | 715 | $71K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,188 | 1,943 | $55K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,310 | 1,214 | $45K |
| 96130 | <1% | 365 | 350 | $15K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 513 | 282 | $14K |
| 99442 | <1% | 312 | 307 | $11K | |
| 97035 | <1% | 1,313 | 682 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 257 | 202 | $9K |
19 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 65 | $8K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 929 | $8K |
| 20553 | <1% | 214 | $7K | |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) | <1% | 229 | $6K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 209 | $5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 227 | $4K |
| J3490 | Unclassified drugs | <1% | 296 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 111 | $2K |
| 20611 | <1% | 20 | $2K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 28 | $2K |
| 64483 | <1% | 13 | $1K | |
| 76942 | <1% | 13 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 136 | $307.89 |
| 96101 | <1% | 27 | $303.15 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 81 | $111.23 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 13 | $12.51 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $10.40 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $10.06 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $0.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTUCK, ROBERT (CONTRACTING / CREDENTIALING)
| Provider | Location | Paid |
|---|---|---|
| Mary Free Bed Orthotics and Prosthetics | Grand Rapids, MI | $7.64M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.